Clinical Trial Update: A Study on the Effection of Potassium Citrate Extended-release Tablets on Urolithiasis Formation or Recurrence [Phase 4]

View source ↗

Summary

Phase 4 trial update on potassium citrate extended-release tablets for formation or recurrence of urolithiasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urolithiasis

Drugs mentioned

• Potassium citrate extended-release tablets (potassium citrate extended-release tablets)

Snippet

Sponsor: Dawnrays Pharmaceutical (Holdings) Limited | Conditions: Urolithiasis | Phase 4 | Status: UNKNOWN